Profil
Charmaine Lykins served as Vice President of Marketing at Lundbeck Pharmaceuticals Ltd.
from 2013 to 2018 and at ACADIA Pharmaceuticals, Inc. from 2018 to 2019.
She will serve as Chief Commercial Officer at Karuna Therapeutics, Inc. from 2021 to 2023.
Lykins earned an undergraduate degree from Ball State University in 1993 and an MBA from Darla Moore School of Business in 2000.
Anciens postes connus de Charmaine Lykins
| Sociétés | Poste | Fin |
|---|---|---|
| KARA THER | Corporate Officer/Principal | 05/01/2023 |
| Lundbeck Pharmaceuticals Ltd. | Sales & Marketing | 01/02/2018 |
| ACADIA PHARMACEUTICALS INC. | Sales & Marketing | - |
Formation de Charmaine Lykins
| Ball State University (Indiana) | Undergraduate Degree |
| Darla Moore School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Lundbeck Pharmaceuticals Ltd. | |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
